|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/21/13 China-Biotics, Inc 10-K 3/31/11 43:4.4M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 918K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 14K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 14K
26: R1 Document and Entity Information HTML 43K
19: R2 Consolidated Balance Sheets HTML 131K
24: R3 Consolidated Balance Sheets [Parenthetical] HTML 43K
28: R4 Consolidated Statements of Income and Other HTML 105K
Comprehensive Income
39: R5 Consolidated Statements of Changes in HTML 59K
Stockholders' Equity
20: R6 Consolidated Statements of Changes in HTML 16K
Stockholders' Equity [Parenthetical]
23: R7 Consolidated Statements of Cash Flow HTML 146K
18: R8 Organization and Description of Business HTML 22K
13: R9 Summary of Principal Accounting Policies HTML 79K
40: R10 Earnings Per Share HTML 32K
30: R11 Risks, Uncertainties, and Concentrations HTML 24K
29: R12 Inventories HTML 21K
34: R13 Land Use Rights HTML 25K
35: R14 Property, Plant and Equipment HTML 25K
33: R15 Amount Due From/To Director HTML 18K
36: R16 Convertible Notes Payable HTML 26K
25: R17 Derivative Liabilities HTML 21K
27: R18 Income Taxes Payable HTML 59K
32: R19 Treasury Stock HTML 17K
43: R20 Capital and Statutory Reserves HTML 17K
37: R21 Option Incentive Plan HTML 31K
21: R22 Product Return Concessions HTML 16K
31: R23 Retirement Costs HTML 27K
22: R24 Commitments and Contingencies HTML 36K
12: R25 Business Segments HTML 53K
38: R26 Selected Quarterly Financial Data HTML 29K
41: R27 Public Offering HTML 17K
17: R28 Subsequent Events HTML 24K
15: R29 Condensed Parent Company Financial Statements HTML 213K
42: XML IDEA XML File -- Filing Summary XML 57K
14: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 549K
6: EX-101.INS XBRL Instance -- chbt-20110331 XML 729K
8: EX-101.CAL XBRL Calculations -- chbt-20110331_cal XML 101K
9: EX-101.DEF XBRL Definitions -- chbt-20110331_def XML 208K
10: EX-101.LAB XBRL Labels -- chbt-20110331_lab XML 470K
11: EX-101.PRE XBRL Presentations -- chbt-20110331_pre XML 280K
7: EX-101.SCH XBRL Schema -- chbt-20110331 XSD 69K
16: ZIP XBRL Zipped Folder -- 0001144204-13-030858-xbrl Zip 74K
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
RULE 15d-14(a) (17 CFR 240.15d-14(a))
(AUTHORIZED BY SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)
I, Song Jinan, certify that:
1. I have reviewed this Annual Report on Form 10-K of China-Biotics, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
| /s/ Song Jinan | |
| Song Jinan | |
| Chief Executive Officer | |
| May 21, 2013 | |
C:
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/21/13 | |||
| For Period end: | 3/31/11 | NT 10-K | ||
| List all Filings | ||||